udp galactose (Biosynth Carbosynth)
Biosynth Carbosynth is a verified supplier 
Biosynth Carbosynth manufactures this product 
92
Structured Review
Biosynth Carbosynth
udp galactose
Udp Galactose, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+galactose/UDP-a-D-galactose+disodium+salt/bio_rxiv__64898__2025__12__15__694461-261-35-37
Average 92 stars, based on 3 article reviews
Udp Galactose, supplied by Biosynth Carbosynth, used in various techniques. Bioz Stars score: 92/100, based on 3 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/udp+galactose/UDP-a-D-galactose+disodium+salt/bio_rxiv__64898__2025__12__15__694461-261-35-37
Average 92 stars, based on 3 article reviews
udp galactose - by Bioz Stars,
2026-09
92/100 stars
Images
Related Articles
Glycoproteomics:Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. For preparation of glycan 5 (R = naphtylmethyl), 8.3 mg of glycan 4 (5.3 μmol) was dissolved in 530 μL of 100 mM MES pH 6.5, supplemented with 10 mM MnCl 2 , 15 mM Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. For preparation of glycan 4 (R = naphtylmethyl), 14.1 mg of glycan 3 (10 μmol) was dissolved in 1 mL of 100 mM TRIS pH 7.5, supplemented with 10 mM MnCl 2 , 15 mM Incubation:Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. For preparation of glycan 5 (R = naphtylmethyl), 8.3 mg of glycan 4 (5.3 μmol) was dissolved in 530 μL of 100 mM MES pH 6.5, supplemented with 10 mM MnCl 2 , 15 mM Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. For preparation of glycan 4 (R = naphtylmethyl), 14.1 mg of glycan 3 (10 μmol) was dissolved in 1 mL of 100 mM TRIS pH 7.5, supplemented with 10 mM MnCl 2 , 15 mM Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. The mAb of interest was diluted to a concentration of 2 mg/mL in 50 mM TRIS pH 7.5, supplemented with 10 mM MnCl 2 , 10 mM Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. The mAb of interest was diluted to a concentration of 2 mg/mL in 50 mM TRIS pH 7.5, supplemented with 10 mM MnCl 2 , 10 mM Synthesized:Article Title: A High-Throughput Glycosyltransferase Inhibition Assay for Identifying Molecules Targeting Fucosylation in Cancer Cell-Surface Modification. Article Snippet: MU-LacNAc was synthesized from 4-methylumbelliferyl-β-N-acetylglucosamine (Carbosynth, EM03177) with the addition of a galactose residue from UDP-galactose (Carbosynth, MU06699), catalyzed by the galactosyltransferase from Helicobacter pylori, HpGalT (HP0826).25 Briefly, in a 2 mL solution buffered with 100 mM Tris-HCl (pH 8) and 10 mM MgCl2, to which 4-methylumbelliferyl-β-N-acetylglucosamine (3.8 DOI: 10.1021/acschembio.8b01123 ACS Chem. Article Title: A High-Throughput Glycosyltransferase Inhibition Assay for Identifying Molecules Targeting Fucosylation in Cancer Cell-Surface Modification. Article Snippet: In cancers, increased fucosylation (attachment of fucose sugar residues) on cell-surface glycans— resulting from the abnormal upregulation in the expression of specific fucosyltransferase enzymes (FUTs)—is one of the most important types of glycan modifications associated with malignancy.. Fucosylated glycans on cell surfaces are involved in a multitude of cellular interactions and signal regulation in normal biological processes.. For example, sialyl LewisX is a fucosylated cell-surface glycan that is abnormally abundant in some cancers where it has been implicated in facilitating metastasis, allowing circulating tumor cells to bind to the epithelial tissue within blood vessels and invade into secondary sites by taking advantage of glycan-mediated interactions. Residue:Article Title: A High-Throughput Glycosyltransferase Inhibition Assay for Identifying Molecules Targeting Fucosylation in Cancer Cell-Surface Modification. Article Snippet: MU-LacNAc was synthesized from 4-methylumbelliferyl-β-N-acetylglucosamine (Carbosynth, EM03177) with the addition of a galactose residue from UDP-galactose (Carbosynth, MU06699), catalyzed by the galactosyltransferase from Helicobacter pylori, HpGalT (HP0826).25 Briefly, in a 2 mL solution buffered with 100 mM Tris-HCl (pH 8) and 10 mM MgCl2, to which 4-methylumbelliferyl-β-N-acetylglucosamine (3.8 DOI: 10.1021/acschembio.8b01123 ACS Chem. Article Title: A High-Throughput Glycosyltransferase Inhibition Assay for Identifying Molecules Targeting Fucosylation in Cancer Cell-Surface Modification. Article Snippet: In cancers, increased fucosylation (attachment of fucose sugar residues) on cell-surface glycans— resulting from the abnormal upregulation in the expression of specific fucosyltransferase enzymes (FUTs)—is one of the most important types of glycan modifications associated with malignancy.. Fucosylated glycans on cell surfaces are involved in a multitude of cellular interactions and signal regulation in normal biological processes.. For example, sialyl LewisX is a fucosylated cell-surface glycan that is abnormally abundant in some cancers where it has been implicated in facilitating metastasis, allowing circulating tumor cells to bind to the epithelial tissue within blood vessels and invade into secondary sites by taking advantage of glycan-mediated interactions. Concentration Assay:Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. The mAb of interest was diluted to a concentration of 2 mg/mL in 50 mM TRIS pH 7.5, supplemented with 10 mM MnCl 2 , 10 mM Article Title: Asymmetrical glycoengineering of monoclonal antibodies: new insights in ɑ-gal immunogenicity Article Snippet: .. The mAb of interest was diluted to a concentration of 2 mg/mL in 50 mM TRIS pH 7.5, supplemented with 10 mM MnCl 2 , 10 mM |